NCT05923060 2026-02-20
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
81 trialsNCT07053852 2026-01-02
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Rochester Dermatologic Surgery
Phase 1 Completed
NCT07290959 2025-12-18
Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK
San Salvatore Hospital of L'Aquila
Phase NA Completed
NCT04223570 2025-11-21
Portable Measurement of Protoporphyrin IX in the Skin
Dartmouth-Hitchcock Medical Center
Completed
NCT06027619 2025-10-23
Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
NCT07049068 2025-09-15
Comparison of Nicotinamide Treatments for Actinic Keratosis
Federal University of Rio Grande do Sul
Phase 1 Completed
NCT06014697 2025-04-04
OCT and Invasion in Cutaneous Skin Lesions
Maastricht University Medical Center
Completed
NCT06712381 2024-12-02
Carac & PDT Combination in the Treatment Of Actinic Keratoses
Skin Laser & Surgery Specialists
Phase 1/2 Completed
NCT03327831 2024-06-27
Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses
University of California, Irvine
Phase 4 Completed
NCT05937529 2024-05-08
Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis
Bispebjerg Hospital
Phase NA Completed
NCT03110159 2024-03-15
DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients
Medical Dermatology Specialists
Phase 1/2 Completed
NCT03246412 2024-03-07
Nevus Doctor Clinical Decision Support for GPs
University Hospital of North Norway
Phase NA Completed
NCT03319251 2023-11-14
Biomarker Database Registry for Photodynamic Therapy
The Cleveland Clinic
Completed
NCT05900258 2023-11-14
SunDamage
Medical University of Graz
Phase 4 Completed
NCT05522036 2023-10-18
Dermaris-35
Centre Dermatologique du Roy
Phase NA Completed
NCT02124733 2023-10-10
Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
The Cleveland Clinic
Phase 3 Completed
NCT00843323 2023-05-10
PDT
University of Sao Paulo
Phase NA Completed
NCT04140292 2022-06-24
Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
NCT02866695 2022-03-09
Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
University of California, San Francisco
Phase 4 Completed
NCT03322293 2022-03-09
Daylight Photodynamic Therapy for Actinic Keratosis
University of California, San Francisco
Phase 1 Completed
NCT04842422 2022-01-11
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
Medical University of Graz
Phase 4 Completed
NCT00558688 2021-12-06
A Photodynamic Therapy for Treatment of Actinic Keratoses
Northwestern University
Phase NA Completed
NCT04843553 2021-04-22
NICE
Rhode Island Hospital
Phase EARLY_PHASE1 Completed
NCT02984072 2021-03-09
MentholPDT
University of Dundee
Phase 4 Completed
NCT03914417 2021-01-20
Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT02736760 2020-11-09
Daylight-PDT With MAL for AK and Photodamaged Skin
University Hospital Regensburg
Phase 4 Completed
NCT03122457 2020-09-04
Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT02878382 2020-08-04
PDT
University of Sao Paulo
Phase NA Completed
NCT03315286 2019-12-18
Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure
Weill Medical College of Cornell University
Phase NA Completed
NCT02990221 2019-09-24
Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy
University of Campania Luigi Vanvitelli
Phase 4 Completed
NCT02446223 2019-09-06
Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%
Goldman, Butterwick, Fitzpatrick and Groff
Phase 4 Completed
NCT03279328 2019-06-25
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
University of Arizona
Phase 4 Completed
NCT02902822 2019-05-17
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Centro Studi Gised
Phase NA Completed
NCT00710489 2019-02-15
Potential Research Study Participant Registry
University of California, Davis
Completed
NCT00103246 2019-01-22
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00695578 2018-12-31
Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy
Wake Forest University Health Sciences
Phase 4 Completed
NCT03731988 2018-11-06
Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis
Dong-A University
Phase 4 Completed
NCT00021294 2018-09-11
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
University of Arizona
Phase 2 Completed
NCT00696488 2018-09-10
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
Wake Forest University Health Sciences
Phase 4 Completed
NCT03037541 2018-08-29
Cryosurgery and Cream Combination for Actinic Keratosis
Wake Forest University Health Sciences
Phase 3 Completed
NCT01444989 2018-08-15
AKRQ
Wake Forest University Health Sciences
Phase NA Completed
NCT03508856 2018-04-26
Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin
Skin Laser & Surgery Specialists
Phase NA Completed
NCT02716714 2018-04-18
Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
Korea University
Phase 4 Completed
NCT02938715 2018-01-16
Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracil
University of California, Davis
Phase NA Completed
NCT03076892 2017-11-14
PHOS-ISTOS
University Hospital, Lille
Phase NA Completed
NCT03325803 2017-10-31
Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis
Dong-A University
Phase 1 Completed
NCT01898936 2017-10-09
Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses
Oslo University Hospital
Phase NA Completed
NCT02062853 2017-07-19
Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video
University of California, Davis
Phase NA Completed
NCT02622594 2017-07-19
Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
Dermatology, Laser & Vein Specialists of the Carolinas
Phase 4 Completed
NCT01459393 2017-06-28
Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment
Barretos Cancer Hospital
Phase 3 Completed